NASDAQ:CLBT Cellebrite DI (CLBT) Stock Price, News & Analysis $10.77 -0.55 (-4.86%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$11.10 +0.33 (+3.10%) As of 11/20/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Cellebrite DI Stock (NASDAQ:CLBT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cellebrite DI alerts:Sign Up Key Stats Today's Range$10.72▼$11.4150-Day Range$10.65▼$12.7052-Week Range$9.58▼$19.39Volume2.71 million shsAverage Volume2.35 million shsMarket Capitalization$2.69 billionP/E Ratio44.88Dividend YieldN/APrice Target$14.75Consensus RatingModerate Buy Company Overview Cellebrite DI Ltd. develops digital intelligence software and services that help organizations access, collect, preserve and analyze digital evidence. Its tools are used to investigate information from mobile devices, computers, cloud sources and other digital systems. The company’s offerings include its UFED platform for extracting data from digital devices, Physical Analyzer for examining and interpreting evidence, and analytics and case-management tools such as Pathfinder and Guardian. Customers include law enforcement, public safety, intelligence and defense agencies, as well as organizations in the private sector. Founded in Israel in 1999, Cellebrite serves customers around the world. The company became publicly traded on the Nasdaq in 2021.AI Generated. May Contain Errors. Read More Cellebrite DI Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks82nd Percentile Overall ScoreCLBT MarketRank™: 4.11430575035 of 5 starsCellebrite DI scored higher than 82% of companies evaluated by MarketBeat, and ranked 180th out of 569 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingModerate Buy Consensus RatingCellebrite DI has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialCellebrite DI has a consensus price target of $14.75, representing about 37.0% upside from its current price of $10.77.Amount of Analyst CoverageCellebrite DI has only been the subject of 4 research reports in the past 90 days.Read more about Cellebrite DI's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth37.84% Earnings GrowthEarnings for Cellebrite DI are expected to grow by 37.84% in the coming year, from $0.37 to $0.51 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cellebrite DI is 44.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.18.Price to Earnings Ratio vs. SectorThe P/E ratio of Cellebrite DI is 44.88, which means that it is trading at a more expensive P/E ratio than the Technology sector average P/E ratio of about 41.15.Price to Earnings Growth RatioCellebrite DI has a PEG Ratio of 1.36. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCellebrite DI has a P/B Ratio of 4.64. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Cellebrite DI's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.40% of the float of Cellebrite DI has been sold short.Short Interest Ratio / Days to CoverCellebrite DI has a short interest ratio ("days to cover") of 4.33.Change versus previous monthShort interest in Cellebrite DI has recently decreased by 21.86%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCellebrite DI does not currently pay a dividend.Dividend GrowthCellebrite DI does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.40 News SentimentCellebrite DI has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Technology companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Cellebrite DI this week, compared to 5 articles on an average week.Search Interest4 people have searched for CLBT on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Cellebrite DI to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cellebrite DI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $761,343.00 in company stock.Percentage Held by Insiders5.70% of the stock of Cellebrite DI is held by insiders.Percentage Held by Institutions45.88% of the stock of Cellebrite DI is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cellebrite DI's insider trading history. Receive CLBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLBT Stock News HeadlinesCellebrite DI (CLBT) Securities Investigation Notice - Levi & KorsinskyNovember 20 at 10:11 AM | prnewswire.comCellebrite DI (NASDAQ:CLBT) Insider Holly Windham Sells 3,049 Shares of Company StockNovember 20 at 7:37 AM | insidertrades.comURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.November 22 at 1:00 AM | Paradigm Press (Ad)Cellebrite DI (NASDAQ:CLBT) CRO Marcus Jewell Sells 9,928 Shares of StockNovember 19 at 7:07 AM | insidertrades.comLevi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Cellebrite DI (CLBT)November 18, 2026 | globenewswire.comZoomInfo, Doximity, Five9, Amplitude, and Cellebrite DI shares plummet, what you need to knowNovember 18, 2026 | theglobeandmail.comCellebrite Cuts Workforce by 7%November 16, 2026 | marketscreener.comMCellebrite Earnings Call Highlights Growth and Genesis MomentumNovember 16, 2026 | theglobeandmail.comSee More Headlines CLBT Stock Analysis - Frequently Asked Questions How have CLBT shares performed this year? Cellebrite DI's stock was trading at $18.03 at the beginning of 2026. Since then, CLBT stock has decreased by 40.3% and is now trading at $10.77. How were Cellebrite DI's earnings last quarter? Cellebrite DI Ltd. (NASDAQ:CLBT) released its quarterly earnings results on Wednesday, February, 11th. The company reported $0.14 EPS for the quarter, meeting the consensus estimate of $0.14. The business's revenue was up 28.8% on a year-over-year basis. Read the conference call transcript. Who are Cellebrite DI's major shareholders? Top institutional shareholders of Cellebrite DI include Phoenix Financial Ltd. (2.05%), Portolan Capital Management LLC (0.79%), State Street Corp (0.46%) and Tensile Capital Management LP (0.33%). Insiders that own company stock include Thomas E Hogan, Marcus Jewell, David Barter and David Nicholas Gee. View institutional ownership trends. How do I buy shares of Cellebrite DI? Shares of CLBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cellebrite DI own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cellebrite DI investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Uber Technologies (UBER), Alphabet (GOOG), Intel (INTC) and Tesla (TSLA). Company Calendar Today11/22/202630th Annual UBS Global Technology and AI Conference12/02/2026Fiscal Year End12/31/2026Next Earnings (Estimated)2/10/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CLBT's financial health is in the Red zone, according to TradeSmith. CLBT has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry Software Sub-IndustryApplication Software Current SymbolNASDAQ:CLBT CIK1854587 Webwww.cellebrite.com Phone972-73-394-8000Fax972-3924-7104Employees1,285Year Founded1999Price Target and Rating Average Price Target for Cellebrite DI$14.75 High Price Target$15.00 Low Price Target$14.00 Potential Upside/Downside+37.0%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$0.24 Trailing P/E Ratio44.88 Forward P/E Ratio21.12 P/E Growth1.36Net Income$78.33 million Net Margins12.14% Pretax Margin15.42% Return on Equity16.91% Return on Assets9.03% Debt Debt-to-Equity RatioN/A Current Ratio1.66 Quick Ratio1.65 Sales & Book Value Annual Sales$537.28 million Price / Sales5.00 Cash Flow$0.40 per share Price / Cash Flow26.65 Book Value$2.32 per share Price / Book4.64Miscellaneous Outstanding Shares249,440,000Free Float235,222,000Market Cap$2.69 billion OptionableOptionable Beta1.06 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NASDAQ:CLBT) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredA quick test most investors failCan you defend your biggest holding? Seeking Alpha Premium gives you its Quant valuation grade versus its sect...Seeking Alpha | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellebrite DI With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.